{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:37:39Z","timestamp":1777689459829,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 2018, an international Task Force formulated recommendations for treating Juvenile Idiopathic Arthritis (JIA) to target. The Task Force has not yet resolved three issues. The first issue is the lack of a single \u201cbest\u201d target. The Task Force decided not to recommend the use of a specific instrument to assess inactive disease or remission. Recent studies underscore the use of a broad target definition. The second issue is the basic assumption that a treatment aggressively aimed at the target will have \u2018domino effects\u2019 on other treatment goals as well. Thus far, this assumption was not confirmed for pain, fatigue and stiffness. The third issue is shared decision-making, and the role of individual patient targets. Nowadays, patients and parents should have a more active role in choosing targets and their personal treatment goals. In our department the electronic medical records have been restructured in such a way that the patient\u2019s personal treatment goals with a target date appears on the front page. The visualization of their specific personal goals helps us to have meaningful discussions on the individualized treatment strategy and to share decisions. In conclusion, a joint treat to target (T2T) strategy is a promising approach for JIA. The Task Force formulated valuable overarching principles and a first version of recommendations. However, implementation of T2T needs to capture more than just inactive disease. Patients and parents should have an active role in choosing personal targets as well.<\/jats:p>","DOI":"10.1186\/s12969-020-00428-7","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T15:04:48Z","timestamp":1587049488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?"],"prefix":"10.1186","volume":"18","author":[{"given":"Casper G.","family":"Schoemaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"428_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","volume":"77","author":"A Ravelli","year":"2018","unstructured":"Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, et al. Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2018;77:819\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213030.","journal-title":"Ann Rheum Dis"},{"key":"428_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/art.40519","volume":"70","author":"SJW Shoop-Worrall","year":"2018","unstructured":"Shoop-Worrall SJW, Verstappen SMM, McDonagh JE, Baildam E, Chieng A, Davidson J, et al. Long-term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis: the importance of definition. Arthritis Rheum. 2018;70:1519\u201329. https:\/\/doi.org\/10.1002\/art.40519.","journal-title":"Arthritis Rheum"},{"key":"428_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000888","volume":"5","author":"M Backstrom","year":"2019","unstructured":"Backstrom M, Tynjala P, Aalto K, Gronlund MM, Ylijoki H, Putto-Laurila A, et al. Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis. RMD Open. 2019;5:e000888. https:\/\/doi.org\/10.1136\/rmdopen-2018-000888.","journal-title":"RMD Open"},{"key":"428_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acr.20205","volume":"62","author":"S Ringold","year":"2010","unstructured":"Ringold S, Bittner R, Neogi T, Wallace CA, Singer NG. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease. Arthritis Care Res. 2010;62:1095\u2013102. https:\/\/doi.org\/10.1002\/acr.20205.","journal-title":"Arthritis Care Res"},{"key":"428_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Rheum. 2019;71:846\u201363. https:\/\/doi.org\/10.1002\/art.40884.","journal-title":"Arthritis Rheum"},{"key":"428_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","volume":"14","author":"A Consolaro","year":"2016","unstructured":"Consolaro A, Giancane G, Schiappapietra B, Davi S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14:23. https:\/\/doi.org\/10.1186\/s12969-016-0085-5.","journal-title":"Pediatr Rheumatol Online J."},{"key":"428_CR7","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290\u20134.","journal-title":"J Rheumatol"},{"key":"428_CR8","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2017-212104","volume":"77","author":"JF Swart","year":"2018","unstructured":"Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S. Clinical juvenile arthritis disease activity score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018;77:336\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212104.","journal-title":"Ann Rheum Dis"},{"key":"428_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3899\/jrheum.180456","volume":"46","author":"J Guzman","year":"2019","unstructured":"Guzman J, Henrey A, Loughin T, Berard RA, Shiff NJ, Jurencak R, et al. Predicting which children with juvenile idiopathic arthritis will not attain early remission with conventional treatment: results from the ReACCh-out cohort. J Rheumatol. 2019;46:628\u201335. https:\/\/doi.org\/10.3899\/jrheum.180456.","journal-title":"J Rheumatol"},{"key":"428_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137. https:\/\/doi.org\/10.1136\/ard.2009.123919.","journal-title":"Ann Rheum Dis"},{"key":"428_CR11","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/rheumatology\/keq195","volume":"49","author":"LG Schipper","year":"2010","unstructured":"Schipper LG, van Hulst LT, Grol R, van Riel PL, Hulscher ME, Fransen J. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Rheumatology (Oxford). 2010;49:2154\u201364. https:\/\/doi.org\/10.1093\/rheumatology\/keq195.","journal-title":"Rheumatology (Oxford)"},{"key":"428_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/BOR.0b013e32832f142e","volume":"21","author":"P Woo","year":"2009","unstructured":"Woo P. Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders. Curr Opin Rheumatol. 2009;21:552\u20137. https:\/\/doi.org\/10.1097\/BOR.0b013e32832f142e.","journal-title":"Curr Opin Rheumatol"},{"key":"428_CR13","doi-asserted-by":"publisher","unstructured":"Morgan EM, Munro JE, Horonjeff J, Horgan B, Shea B, Feldman BM, et al. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA workshop. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.181088.","DOI":"10.3899\/jrheum.181088"},{"key":"428_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2217\/pmt.14.6","volume":"4","author":"MH Bromberg","year":"2014","unstructured":"Bromberg MH, Schechter NL, Nurko S, Zempsky WT, Schanberg LE. Persistent pain in chronically ill children without detectable disease activity. Pain Manag. 2014;4:211\u20139. https:\/\/doi.org\/10.2217\/pmt.14.6.","journal-title":"Pain Manag"},{"key":"428_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.38223","volume":"66","author":"MH Bromberg","year":"2014","unstructured":"Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE. Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study. Arthritis Rheum. 2014;66:462\u20139. https:\/\/doi.org\/10.1002\/art.38223.","journal-title":"Arthritis Rheum"},{"key":"428_CR16","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/rheumatology\/kev195","volume":"54","author":"J Anink","year":"2015","unstructured":"Anink J, Prince FH, Dijkstra M, Otten MH, Twilt M, ten Cate R, et al. Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch arthritis and Biologicals in children register. Rheumatology. 2015;54:1964\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kev195.","journal-title":"Rheumatology."},{"key":"428_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-11-21","volume":"11","author":"JJ Lomholt","year":"2013","unstructured":"Lomholt JJ, Thastum M, Herlin T. Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment. Pediatr Rheumatol Online J. 2013;11:21. https:\/\/doi.org\/10.1186\/1546-0096-11-21.","journal-title":"Pediatr Rheumatol Online J"},{"key":"428_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/j.pain.0000000000001064","volume":"159","author":"NJ Shiff","year":"2018","unstructured":"Shiff NJ, Tupper S, Oen K, Guzman J, Lim H, Lee CH, et al. Trajectories of pain severity in juvenile idiopathic arthritis: results from the research in arthritis in Canadian children emphasizing outcomes cohort. Pain. 2018;159:57\u201366. https:\/\/doi.org\/10.1097\/j.pain.0000000000001064.","journal-title":"Pain."},{"key":"428_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12969-016-0125-1","volume":"14","author":"W Armbrust","year":"2016","unstructured":"Armbrust W, Lelieveld OH, Tuinstra J, Wulffraat NM, Bos GJ, Cappon J, et al. Fatigue in patients with juvenile idiopathic arthritis: relationship to perceived health, physical health, self-efficacy, and participation. Pediatr Rheumatol Online J. 2016;14:65. https:\/\/doi.org\/10.1186\/s12969-016-0125-1.","journal-title":"Pediatr Rheumatol Online J."},{"key":"428_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/acr.22710","volume":"68","author":"LN Nijhof","year":"2016","unstructured":"Nijhof LN, van de Putte EM, Wulffraat NM, Nijhof SL. Prevalence of severe fatigue among adolescents with pediatric rheumatic diseases. Arthritis Care Res. 2016;68:108\u201314. https:\/\/doi.org\/10.1002\/acr.22710.","journal-title":"Arthritis Care Res"},{"key":"428_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/acr.21801","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Ward TM, Wallace CA. Disease activity and fatigue in juvenile idiopathic arthritis. Arthritis Care Res. 2013;65:391\u20137. https:\/\/doi.org\/10.1002\/acr.21801.","journal-title":"Arthritis Care Res"},{"key":"428_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3899\/jrheum.190268","volume":"47","author":"L Buckley","year":"2020","unstructured":"Buckley L, Ware E, Kreher G, Wiater L, Mehta J, Burnham JM. Outcome monitoring and clinical decision support in Polyarticular juvenile idiopathic arthritis. J Rheumatol. 2020;47:273\u201381. https:\/\/doi.org\/10.3899\/jrheum.190268.","journal-title":"J Rheumatol"},{"key":"428_CR23","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00296-018-4136-8","volume":"38","author":"LN Nijhof","year":"2018","unstructured":"Nijhof LN, Nap-van der Vlist MM, van de Putte EM, van Royen-Kerkhof A, Nijhof SL. Non-pharmacological options for managing chronic musculoskeletal pain in children with pediatric rheumatic disease: a systematic review. Rheumatol Int. 2018;38:2015\u201325. https:\/\/doi.org\/10.1007\/s00296-018-4136-8.","journal-title":"Rheumatol Int"},{"key":"428_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1546-0096-11-34","volume":"11","author":"EA Lipstein","year":"2013","unstructured":"Lipstein EA, Brinkman WB, Sage J, Lannon CM, Morgan DE. Understanding treatment decision making in juvenile idiopathic arthritis: a qualitative assessment. Pediatr Rheumatol Online J. 2013;11:34. https:\/\/doi.org\/10.1186\/1546-0096-11-34.","journal-title":"Pediatr Rheumatol Online J."},{"key":"428_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jpeds.2015.12.071","volume":"171","author":"CM Dodds","year":"2016","unstructured":"Dodds CM, Britto MT, Denson LA, Lovell DJ, Saeed S, Lipstein EA. Physicians' Perceptions of Shared Decision Making in Chronic Disease and Its Barriers and Facilitators. Journal Pediatr. 2016;171:307\u20139.e1\u20132. https:\/\/doi.org\/10.1016\/j.jpeds.2015.12.071.","journal-title":"Journal Pediatr"},{"key":"428_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/acr.23236","volume":"70","author":"K Oen","year":"2018","unstructured":"Oen K, Guzman J, Dufault B, Tucker LB, Shiff NJ, Duffy KW, et al. Health-related quality of life in an inception cohort of children with juvenile idiopathic arthritis: a longitudinal analysis. Arthritis Care Res. 2018;70:134\u201344. https:\/\/doi.org\/10.1002\/acr.23236.","journal-title":"Arthritis Care Res"},{"key":"428_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10067-010-1444-0","volume":"30","author":"L Eyckmans","year":"2011","unstructured":"Eyckmans L, Hilderson D, Westhovens R, Wouters C, Moons P. What does it mean to grow up with juvenile idiopathic arthritis? A qualitative study on the perspectives of patients. Clin Rheumatol. 2011;30:459\u201365. https:\/\/doi.org\/10.1007\/s10067-010-1444-0.","journal-title":"Clin Rheumatol"},{"key":"428_CR28","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/acr.21695","volume":"64","author":"A Tong","year":"2012","unstructured":"Tong A, Jones J, Craig JC, Singh-Grewal D. Children's experiences of living with juvenile idiopathic arthritis: a thematic synthesis of qualitative studies. Arthritis Care Res. 2012;64:1392\u2013404. https:\/\/doi.org\/10.1002\/acr.21695.","journal-title":"Arthritis Care Res"},{"key":"428_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12969-018-0276-3","volume":"16","author":"CG Schoemaker","year":"2018","unstructured":"Schoemaker CG, Armbrust W, Swart JF, Vastert SJ, van Loosdregt J, Verwoerd A, et al. Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol. Pediatr Rheumatol Online J. 2018;16:57. https:\/\/doi.org\/10.1186\/s12969-018-0276-3.","journal-title":"Pediatr Rheumatol Online J."},{"key":"428_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41584-018-0129-y","volume":"15","author":"LE Schanberg","year":"2019","unstructured":"Schanberg LE, Mullins CD. If patients are the true north, patient-centeredness should guide research. Nat Rev Rheumatol. 2019;15:5\u20136. https:\/\/doi.org\/10.1038\/s41584-018-0129-y.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-020-00428-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T01:26:24Z","timestamp":1618536384000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-020-00428-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1186\/s12969-020-00428-7","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"23 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}